Your browser doesn't support javascript.
loading
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
Iatropoulos, Paraskevas; Noris, Marina; Mele, Caterina; Piras, Rossella; Valoti, Elisabetta; Bresin, Elena; Curreri, Manuela; Mondo, Elena; Zito, Anna; Gamba, Sara; Bettoni, Serena; Murer, Luisa; Fremeaux-Bacchi, Veronique; Vivarelli, Marina; Emma, Francesco; Daina, Erica; Remuzzi, Giuseppe.
Affiliation
  • Iatropoulos P; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Noris M; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Mele C; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Piras R; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Valoti E; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Bresin E; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Curreri M; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Mondo E; Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Zito A; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Gamba S; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Bettoni S; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
  • Murer L; Unit of Pediatric Nephrology, Dialysis and Transplantation, Azienda Ospedaliera of Padova, Italy.
  • Fremeaux-Bacchi V; Department of Immunology, Assistance Publique-Hopitaux de Paris, Hopital Europeen George-Pompidou and INSERM UMRS 1138, Cordelier Research Center, Complement and Diseases Team, Paris, France.
  • Vivarelli M; Division of Nephrology and Dialysis, Bambin Gesù Pediatric Hospital, Roma, Italy.
  • Emma F; Division of Nephrology and Dialysis, Bambin Gesù Pediatric Hospital, Roma, Italy.
  • Daina E; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy. Electronic address: erica.daina@marionegri.it.
  • Remuzzi G; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy; Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy; Department of Biomedical and Clinical Sciences, University of Milan,
Mol Immunol ; 71: 131-142, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26895476

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Glomerulonephritis, Membranoproliferative / Thrombomodulin / Complement Pathway, Alternative Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Mol Immunol Year: 2016 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Glomerulonephritis, Membranoproliferative / Thrombomodulin / Complement Pathway, Alternative Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Mol Immunol Year: 2016 Document type: Article Affiliation country: